An in vivo study of the Eμ-Myc mouse model of B-cell lymphoma using B-cells at three different stages of lymphomagenesis, each with different MYC levels, identified almost four thousand significantly changed genes between cells representing the different stages [18]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.